ArticleCureus2026
Predictors of Outcomes in Pediatric Acute Respiratory Distress Syndrome at a Tertiary Care Hospital.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAcute respiratory distress syndrome (ARDS) in children remains a critical cause of morbidity and mortality worldwide, yet regional data from Kashmir are limited. This study aimed to evaluate the predictors of outcomes among pediatric ARDS cases admitted to a tertiary care center.
methodsA prospective observational study was conducted over two years, enrolling 40 children diagnosed with ARDS at a pediatric department using a consecutive sampling method. Demographic characteristics, clinical features, laboratory trends, arterial blood gas (ABG) parameters, and severity scores (Lung Injury Score (LIS), Pediatric Sequential Organ Failure Assessment (pSOFA), and Pediatric Risk of Mortality III (PRISM III)) were analyzed to identify factors associated with disease progression and mortality.
resultsMost affected children were below six years of age, with male children comprising the majority. Fever, cough, tachypnea, crepitations, and hypoxemia were main clinical features. A significant rise in blood urea and creatinine emerged during progression, reflecting renal involvement. High total leukocyte count (TLC), neutrophilia, and inflammatory markers were associated with severe disease. Non-survivors exhibited markedly deranged ABG profiles-including lower pH, reduced PO₂, and elevated lactate-indicating uncompensated hypoxia and acidosis. Severity indices (LIS, pSOFA, and PRISM III) and oxygenation parameters significantly predicted mortality. Multiorgan dysfunction, particularly renal and hepatic impairment, was more frequent in non-survivors.
conclusionARDS continues to carry high mortality in resource-limited settings. Younger age, elevated inflammatory and organ dysfunction markers, worsening ABG parameters, and higher severity scores were strongly associated with poor outcomes. Early identification of high-risk children, timely escalation of respiratory support, improved referral pathways, and strengthening of pediatric critical care services are essential to enhance survival in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.